J. Goldman & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-74,185
| Closed | -$20M | – | 319 |
|
2025
Q1 | $20M | Buy |
+74,185
| New | +$20M | 0.49% | 46 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 317 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 321 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 303 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 241 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 260 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 232 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 236 |
|